FindTrial
Sign In

68Ga-NODAGA-R01 PET/CT in the diagnosis of pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, cervical cancer, ovarian cancer, brain glioma

the value of 68Ga-NODAGA-R01 PET/CT in patients with pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, cervical cancer, ovarian cancer, brain glioma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16007735
Enrollment
Unknown
Registered
2016-01-11
Start date
2016-01-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Gold Standard:
Index test:

Sponsors

Department of Nuclear medicine,Peking Union Medical College Hospital,Peking Union Medical College, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 20-70 years old; 2. the final diagnosis by pathology with surgical or biopsy; 3. informed consent and be able to follow up. .

Exclusion criteria

Exclusion criteria: Women in pregnancy and lactation were excluded; The patients with severe disease were excluded;

Design outcomes

Primary

MeasureTime frame
SUVmax;—

Countries

China

Contacts

Public ContactFang Li
lifang@pumch.cn+86 010 69155502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026